We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.36B
AUM Growth
+$353M
(+5.9%)
Cap. Flow
+$69.5M
Cap. Flow
% of AUM
1.09%
Top 10 Holdings %
Top 10 Hldgs %
13.3%
Holding
1,175
New
186
Increased
412
Reduced
363
Closed
161
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ConocoPhillips
COP
|
+$25.8M |
| 2 |
Amazon
AMZN
|
+$22.7M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$20.3M |
| 4 |
Everest Group
EG
|
+$18.9M |
| 5 |
LKQ Corp
LKQ
|
+$16.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$36M |
| 2 |
UnitedHealth
UNH
|
+$29.5M |
| 3 |
Merck
MRK
|
+$17.8M |
| 4 |
Baxter International
BAX
|
+$17.5M |
| 5 |
Apple
AAPL
|
+$17.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.46% |
| 2 | Financials | 17.64% |
| 3 | Consumer Discretionary | 12.58% |
| 4 | Industrials | 12.01% |
| 5 | Healthcare | 10.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Novavax
NVAX
$1.23B
| $1.18M | 0.02% |
44,085
-9,526
| -18% | -$322K |
|
|
CMRX
627
DELISTED
Chimerix, Inc.
CMRX
| $1.18M | 0.02% |
246,916
-27,179
| -10% | -$130K |
|
628
Berkshire Hathaway Class B
BRK.B
$1.07T
| $1.17M | 0.02% |
6,252
-4,740
| -43% | -$924K |
|
629
OSI Systems
OSIS
$3.57B
| $1.17M | 0.02% |
+15,070
| New | +$1.05M |
|
|
NUAN
630
DELISTED
Nuance Communications, Inc.
NUAN
| $1.16M | 0.02% |
96,466
-151,767
| -61% | -$1.88M |
|
|
MRTX
631
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.16M | 0.02% |
23,500
| – | – |
|
632
VICI Properties
VICI
$29.4B
| $1.14M | 0.02% |
+55,400
| New | +$1.07M |
|
|
HIBB
633
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $1.14M | 0.02% |
49,683
-22,900
| -32% | -$597K |
|
634
Norfolk Southern
NSC
$78.8B
| $1.14M | 0.02% |
7,520
-63,951
| -89% | -$9.35M |
|
|
ARRY
635
DELISTED
Array Biopharma Inc
ARRY
| $1.13M | 0.02% |
67,560
-20,200
| -23% | -$321K |
|
|
LCI
636
DELISTED
Lannett Company, Inc.
LCI
| $1.12M | 0.02% |
+20,627
| New | +$1.3M |
|
637
NextEra Energy
NEE
$187B
| $1.12M | 0.02% |
26,760
+14,520
| +119% | +$586K |
|
638
Vistra
VST
$55.1B
| $1.11M | 0.02% |
47,000
-39,400
| -46% | -$906K |
|
|
LEXEA
639
DELISTED
Liberty Expedia Holdings, Inc. Class A Common Stock
LEXEA
| $1.11M | 0.02% |
+25,300
| New | +$1.06M |
|
640
First Financial Corp
THFF
$922M
| $1.11M | 0.02% |
24,500
+160
| +0.7% | +$6.99K |
|
|
QADA
641
DELISTED
QAD Inc.
QADA
| $1.11M | 0.02% |
22,081
-21,539
| -49% | -$1.04M |
|
|
GNMK
642
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1.1M | 0.02% |
173,247
-38,417
| -18% | -$254K |
|
|
ZAYO
643
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $1.1M | 0.02% |
30,180
+1,900
| +7% | +$67.7K |
|
644
Heritage Financial
HFWA
$1.24B
| $1.1M | 0.02% |
31,532
+2,010
| +7% | +$64.4K |
|
645
Pixelworks
PXLW
$38.8M
| $1.1M | 0.02% |
25,289
-4,305
| -15% | -$211K |
|
646
Verastem
VSTM
$532M
| $1.09M | 0.02% |
13,258
+125
| +1% | +$7.65K |
|
|
BMCH
647
DELISTED
BMC Stock Holdings, Inc
BMCH
| $1.09M | 0.02% |
52,528
-53,027
| -50% | -$1.05M |
|
|
ECOM
648
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $1.08M | 0.02% |
77,056
-10,400
| -12% | -$136K |
|
649
Community Trust Bancorp
CTBI
$1.38B
| $1.08M | 0.02% |
21,595
-592
| -3% | -$29.3K |
|
650
Tandem Diabetes Care
TNDM
$1.17B
| $1.08M | 0.02% |
48,949
-3,401
| -6% | -$41.8K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2018 Portfolio in Review
As of Q2 2018, Jacobs Levy Equity Management held 1,175 positions worth $6.36B, up 5.9% from $6.01B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management's Q2 2018 filing shows 186 new, 412 increased, 363 reduced and 161 closed positions. Its largest new stake was LKQ Corp: 486,474 shares worth $15.5M. The largest sale was PepsiCo, an estimated $36M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2018 buy was LKQ Corp: 486,474 shares worth $15.5M.
- Jacobs Levy Equity Management added most to ConocoPhillips in Q2 2018, an estimated $25.8M increase.
- Jacobs Levy Equity Management's biggest Q2 2018 reduction was PepsiCo, cutting an estimated $36M.
- Jacobs Levy Equity Management fully exited General Dynamics in Q2 2018, selling an estimated $11M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $6.36B portfolio in Q2 2018.
- Jacobs Levy Equity Management opened 186 new positions and closed 161 in Q2 2018.
- Jacobs Levy Equity Management's portfolio value rose 5.9% quarter-over-quarter to $6.36B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2018, filed 14 Aug 2018.